
TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
Author(s) -
Marianna B. Ruzinova,
Yi-Shan Lee,
Eric J. Duncavage,
John S. Welch
Publication year - 2019
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.205302
Subject(s) - decitabine , immunohistochemistry , myeloid , medicine , myeloid leukemia , mutation , oncology , biology , gene , genetics , dna methylation , gene expression